Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 24, 2021PharmaceuticsOpen Access

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSarah ShigdarDeakin UniversityLALisa AgnelloNational Academies of Sciences, Engineering, and MedicineMFMonica FedeleNational Academies of Sciences, Engineering, and Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shigdar et al. (2021) studied this question.

synapsesocial.com/papers/6a1597ab37103a43379ff419https://doi.org/10.3390/pharmaceutics14010028
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology2021 · 211 citations
  2. 2Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers2017 · 93 citations
  3. 3Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer2020 · 72 citations
  4. 4Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples2007 · 152 citations
  5. 5Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer2017 · 95 citations